These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27747165)

  • 1. Use of bio-informatics assessment schema (BIAS) to improve diagnosis and prognosis of myocardial perfusion data: results from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE).
    Doyle M; Pohost GM; Bairey Merz CN; Shaw LJ; Sopko G; Rogers WJ; Sharaf BL; Pepine CJ; Thompson DV; Rayarao G; Tauxe L; Kelsey SF; Biederman RW
    Cardiovasc Diagn Ther; 2016 Oct; 6(5):424-431. PubMed ID: 27747165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved diagnosis and prognosis using Decisions Informed by Combining Entities (DICE): results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).
    Doyle M; Pohost GM; Merz CN; Shaw LJ; Sopko G; Rogers WJ; Sharaf BL; Pepine CJ; Vido-Thompson DA; Rayarao G; Tauxe L; Kelsey SF; Mc Nair D; Biederman RW
    Cardiovasc Diagn Ther; 2013 Dec; 3(4):216-27. PubMed ID: 24400205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left Ventricular Energy Model Predicts Adverse Events in Women With Suspected Myocardial Ischemia: Results From The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study.
    Doyle M; Weinberg N; Pohost GM; Merz CN; Shaw LJ; Sopko G; Fuisz A; Rogers WJ; Walsh EG; Johnson BD; Sharaf BL; Pepine CJ; Mankad S; Reis SE; Rayarao G; Vido DA; Bittner V; Tauxe L; Olson MB; Kelsey SF; Biederman RW
    Cardiovasc Diagn Ther; 2013 Jun; 3(2):64-72. PubMed ID: 24015377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive coronary disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.
    Doyle M; Weinberg N; Pohost GM; Bairey Merz CN; Shaw LJ; Sopko G; Fuisz A; Rogers WJ; Walsh EG; Johnson BD; Sharaf BL; Pepine CJ; Mankad S; Reis SE; Vido DA; Rayarao G; Bittner V; Tauxe L; Olson MB; Kelsey SF; Biederman RW
    JACC Cardiovasc Imaging; 2010 Oct; 3(10):1030-6. PubMed ID: 20947048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of myocardial perfusion imaging with D-SPECT camera in patients with ischemia and no obstructive coronary artery disease (INOCA).
    Liu L; Abdu FA; Yin G; Xu B; Mohammed AQ; Xu S; Lv X; Luo Y; Zu L; Yang C; Zhang Z; Zhou Y; Cai H; Lv Z; Xu Y; Che W
    J Nucl Cardiol; 2021 Dec; 28(6):3025-3037. PubMed ID: 33000403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Predictive value of left ventricular ejection fraction reserve assessed by SPECT G-MPI for major adverse cardiovascular event in patients with coronary artery disease].
    Zhou YH; Lu Y; Meng JJ; Mou TT; Bai YJ; Zhang S; Zheng YQ; Deng QJ; Jiao J; Chang Z; Xie XF; Yun MK; Mi HZ; Li X; Zhang XL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Jun; 51(6):626-632. PubMed ID: 37312481
    [No Abstract]   [Full Text] [Related]  

  • 7. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epicardial fat volume, an independent risk factor for major adverse cardiovascular events, had an incremental prognostic value to myocardial perfusion imaging in Chinese populations with suspected or known coronary artery disease with a normal left ventricular ejection fraction.
    Yang L; Yu W; Wan P; Wang J; Shao X; Zhang F; Yang X; Chen Y; Li Q; Jiang D; Wang Y; Jiang Q; Wang J; Wang Y
    Front Cardiovasc Med; 2023; 10():1261215. PubMed ID: 37849937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic and prognostic value of near-normal perfusion or borderline ischemia on stress myocardial perfusion imaging.
    Kassab K; Hussain K; Torres A; Iskander F; Iskander M; Khan R; Doukky R
    J Nucl Cardiol; 2022 Apr; 29(2):826-835. PubMed ID: 33034835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized Comparison of Clinical Effectiveness of Pharmacologic SPECT and PET MPI in Symptomatic CAD Patients.
    Patel KK; Al Badarin F; Chan PS; Spertus JA; Courter S; Kennedy KF; Case JA; McGhie AI; Heller GV; Bateman TM
    JACC Cardiovasc Imaging; 2019 Sep; 12(9):1821-1831. PubMed ID: 31326480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic implications of ST-segment and T-wave abnormalities in patients undergoing regadenoson stress SPECT myocardial perfusion imaging.
    Khan MS; Arif AW; Doukky R
    J Nucl Cardiol; 2022 Apr; 29(2):810-821. PubMed ID: 33034037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single photon emission computed tomography for the diagnosis of coronary artery disease: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(8):1-64. PubMed ID: 23074411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic efficiency and incremental value of myocardial blood flow quantification by CZT SPECT for patients with coronary artery disease].
    Pang ZK; Wang J; Chen Y; Chu HX; Zhang MY; Li JM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 May; 50(5):494-500. PubMed ID: 35589599
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic value of regadenoson stress myocardial perfusion imaging in patients with left bundle branch block or ventricular paced rhythm.
    Iskander F; Iskander M; Gomez J; Doukky R
    J Nucl Cardiol; 2021 Jun; 28(3):967-977. PubMed ID: 31144225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absolute quantification of left ventricular global and regional function at nuclear MPI using ultrafast CZT SPECT: initial validation versus cardiac MR.
    Cochet H; Bullier E; Gerbaud E; Durieux M; Godbert Y; Lederlin M; Coste P; Barat JL; Laurent F; Montaudon M
    J Nucl Med; 2013 Apr; 54(4):556-63. PubMed ID: 23385955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(16):1-80. PubMed ID: 23074393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac magnetic resonance imaging for the diagnosis of coronary artery disease: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(12):1-38. PubMed ID: 23074389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the extent and severity of myocardial perfusion defects measured by CT coronary angiography and SPECT myocardial perfusion imaging.
    Tamarappoo BK; Dey D; Nakazato R; Shmilovich H; Smith T; Cheng VY; Thomson LE; Hayes SW; Friedman JD; Germano G; Slomka PJ; Berman DS
    JACC Cardiovasc Imaging; 2010 Oct; 3(10):1010-9. PubMed ID: 20947046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic performance of SPECT-MPI to predict functional significant coronary artery disease by fractional flow reserve derived from CCTA (FFR
    Nakanishi R; Osawa K; Ceponiene I; Huth G; Cole J; Kim M; Nezarat N; Rahmani S; Li D; Gupta S; Rogers C; Dailing C; Budoff MJ
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):2067-2072. PubMed ID: 28699019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.